Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
Frontiers in Pharmacology（2013）
Key words
acute myeloid leukemia,inv(3)(q21g26.2),darinaparsin,experimental treatment,resistance,personalized medicine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined